Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with HHS Peptides Move: Compounding Pharmacy Concerns Scott Brunner, CAE posted on the topic LinkedIn Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg #